[Immunomodulating therapy of rheumatoid arthritis].
Balabanova
R M
RM
Barakat
B
B
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology; D007978:Levamisole / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000276:immunology; D013949:Thymus Extracts / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; D007978:Levamisole; C036191:T-activin; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate
Immunomoduliruiushchaia terapiia revmatoidnogo artrita.